Log in to save to my catalogue

The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effectiv...

The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effectiv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_894814031

The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effective Therapeutic Option in Patients with Advanced or Metastatic Bladder Cancer

About this item

Full title

The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effective Therapeutic Option in Patients with Advanced or Metastatic Bladder Cancer

Publisher

England: The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology

Journal title

Journal of radiation research, 2011-09, Vol.52 (5), p.674-679

Language

English

Formats

Publication information

Publisher

England: The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology

More information

Scope and Contents

Contents

The objectives of this study were to determine the tolerability of combined use of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) with external beam radiation therapy (EBRT) and to access the efficacy in patients with locally advanced or metastatic bladder cancer. From December 2000 to November 2010, 30 eligible patients were enrolled...

Alternative Titles

Full title

The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effective Therapeutic Option in Patients with Advanced or Metastatic Bladder Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_894814031

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_894814031

Other Identifiers

ISSN

0449-3060,1349-9157

E-ISSN

1349-9157

DOI

10.1269/jrr.11036

How to access this item